M&T Bank Corp Buys 1,535 Shares of Phreesia, Inc. (NYSE:PHR)

M&T Bank Corp lifted its stake in Phreesia, Inc. (NYSE:PHR) by 4.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,127 shares of the company’s stock after buying an additional 1,535 shares during the period. M&T Bank Corp owned approximately 0.06% of Phreesia worth $801,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Bank of New York Mellon Corp increased its stake in Phreesia by 8.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock worth $4,546,000 after purchasing an additional 16,614 shares during the period. Peregrine Capital Management LLC increased its stake in shares of Phreesia by 11.3% in the second quarter. Peregrine Capital Management LLC now owns 354,607 shares of the company’s stock worth $7,518,000 after buying an additional 36,047 shares during the period. nVerses Capital LLC raised its holdings in Phreesia by 76.5% during the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after buying an additional 1,300 shares during the last quarter. Rhumbline Advisers boosted its position in Phreesia by 1.0% during the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after buying an additional 853 shares during the period. Finally, Arcadia Investment Management Corp MI grew its holdings in Phreesia by 13.9% in the 2nd quarter. Arcadia Investment Management Corp MI now owns 88,625 shares of the company’s stock worth $1,879,000 after acquiring an additional 10,800 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

PHR has been the subject of several recent analyst reports. Robert W. Baird lowered their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Truist Financial increased their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Canaccord Genuity Group restated a “buy” rating and set a $34.00 target price on shares of Phreesia in a report on Thursday, September 5th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, September 9th. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $29.33.

Insiders Place Their Bets

In related news, insider Yvonne Hui sold 2,791 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $20.92, for a total transaction of $58,387.72. Following the completion of the sale, the insider now owns 27,228 shares of the company’s stock, valued at $569,609.76. This trade represents a 9.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP David Linetsky sold 11,853 shares of the business’s stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $24.85, for a total transaction of $294,547.05. Following the completion of the transaction, the senior vice president now owns 188,354 shares of the company’s stock, valued at approximately $4,680,596.90. The trade was a 5.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 65,386 shares of company stock valued at $1,416,670. 5.80% of the stock is currently owned by corporate insiders.

Phreesia Stock Up 2.9 %

NYSE:PHR opened at $25.66 on Tuesday. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The company has a market capitalization of $1.49 billion, a PE ratio of -17.46 and a beta of 0.98. The firm’s 50-day moving average price is $20.53 and its 200-day moving average price is $21.84. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter last year, the firm earned ($0.58) earnings per share. On average, equities analysts predict that Phreesia, Inc. will post -1.16 EPS for the current fiscal year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.